Alzamend Neuro share price today

(ALZN)

Alzamend Neuro share price is $1.19 & ₹101.39 as on 25 Dec 2024, 2.30 'hrs' IST

$1.19

▲

0.04

(3.48%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Alzamend Neuro share price in Dollar and Rupees. Guide to invest in Alzamend Neuro from India. Also see the sentimental analysis on Indian investors investing in Alzamend Neuro. Get details on the Indian mutual funds that are investing in Alzamend Neuro. Get Analyst recommendations and forecasts along with all the Alzamend Neuro's financials.

Alzamend Neuro share price movements

Today's Low: $1.11
Today's High: $1.20
$1.19
6.72%
Downside
Day's Volatility :7.5%
Upside
0.83%
52 Weeks Low: $1.06
52 Weeks High: $15.06
$1.19
10.92%
Downside
52 Weeks Volatility :92.96%
Upside
92.1%

Alzamend Neuro Returns

Period	Alzamend Neuro Inc	Index (Russel 2000)
3 Months	-30.41%	0.0%
6 Months	-70.25%	0.0%
1 Year	-86.55%	0.0%
3 Years	-99.63%	-21.1%

Alzamend Neuro Key Statistics

in dollars & INR

Previous Close	$1.15
Open	$1.17
Today's High	$1.2
Today's Low	$1.11
Market Capitalization	$6.2M
Today's Volume	$47.0K
52 Week High	$15.06
52 Week Low	$1.06
Revenue TTM	$0.0
EBITDA	$-7.3M
Earnings Per Share (EPS)	$-138.31
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-4408.31%

How to invest in Alzamend Neuro from India?

It is very easy for Indian residents to invest directly in Alzamend Neuro from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Alzamend Neuro stock in both Indian Rupees (INR) and US Dollars (USD). Search for Alzamend Neuro or ALZN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Alzamend Neuro or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Alzamend Neuro shares which would translate to 0.716 fractional shares of Alzamend Neuro as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Alzamend Neuro, in just a few clicks!

Returns in Alzamend Neuro for Indian investors in Rupees

Investment Value

₹1,00,000

Alzamend Neuro investment value today

Current value as on today

₹15,872

Returns

₹84,128

(-84.13%)

Returns from Alzamend Neuro Stock

₹86,554 (-86.55%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Alzamend Neuro

-32%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Alzamend Neuro on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -32% less investors are searching Alzamend Neuro in the last 30 days versus the previous period.

Global Institutional Holdings in Alzamend Neuro

Susquehanna International Group, LLP
0.37%
BB&T Corp.
0.35%
Tower Research Capital LLC
0.09%
Wells Fargo & Co
0.02%
CoreCap Advisors, LLC
0.02%

Analyst Recommendation on Alzamend Neuro

Buy

75%Buy

25%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Alzamend Neuro(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Alzamend Neuro

What analysts predicted

Upside of 2589.08%

Current:

$1.19

Target:

$32.00

Insights on Alzamend Neuro

Price Movement
In the last 6 months, ALZN stock has moved down by -68.8%
ALZN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.3% return, outperforming this stock by 114.1%
ALZN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 124.8%

Alzamend Neuro Technicals Summary

Sell

Neutral

Buy

Alzamend Neuro is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Alzamend Neuro Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Alzamend Neuro Inc	-7.39%	-70.25%	-86.55%	-99.63%	-99.94%
Regeneron Pharmaceuticals, Inc.	-4.68%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-5.49%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.08%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-11.59%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Alzamend Neuro Inc	NA	NA	NA	-14.5	-44.08	-2.14	NA	-3.77
Regeneron Pharmaceuticals, Inc.	17.7	17.7	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Alzamend Neuro Inc	Buy	$6.2M	-99.94%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.6B	91.19%	17.7	33.61%
Biontech Se	Buy	$27.2B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.2B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$104.4B	86.41%	32.84	-4.51%

About Alzamend Neuro

alzamend neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of alzheimer’s disease, bipolar disorder, major depressive disorder (“mdd”) and post-traumatic stress disorder (“ptsd”). our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43+ million americans suffering from these debilitating diseases. our current pipeline consists of two novel therapeutic drug candidates, al001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and alzn002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat alzheimer’s.

Organization	Alzamend Neuro
Employees	4
CEO	Mr. Stephan Jackman
Industry	Miscellaneous

Management People of Alzamend Neuro

Name	Title
Mr. Stephan Jackman	CEO & Director
Mr. Milton Charles Ault III	Founder & Vice Chairman
Mr. David J. Katzoff	Chief Financial Officer
Mr. Henry C. W. Nisser Esq.	Executive VP, General Counsel & Director
Mr. Kenneth S. Cragun CPA	Senior Vice President of Finance

Important FAQs about investing in Alzamend Neuro from India :

What is Alzamend Neuro share price today?

Alzamend Neuro share price today stands at $1.19, Open: $1.17 ; Previous Close: $1.15 ; High: $1.20 ; Low: $1.11 ; 52 Week High: $15.06 ; 52 Week Low: $1.06. The stock opens at $1.17, after a previous close of $1.15. The stock reached a daily high of $1.20 and a low of $1.11, with a 52-week high of $15.06 and a 52-week low of $1.06.

Can Indians buy Alzamend Neuro shares?

Yes, Indians can invest in the Alzamend Neuro (ALZN) from India.

With INDmoney, you can buy Alzamend Neuro at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Alzamend Neuro at zero transaction cost.

How can I buy Alzamend Neuro shares from India?

It is very easy to buy Alzamend Neuro from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Alzamend Neuro be purchased?

Yes, you can buy fractional shares of Alzamend Neuro with INDmoney app.

What are the documents required to start investing in Alzamend Neuro stocks?

To start investing in Alzamend Neuro, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.